P5 Health Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Leviantleviant.cominJun 2026
Leviant designs and manufactures UV-C sanitization devices for indoor environments using proprietary FMUV technology that eliminates shadow zones.
CleantechHardwareHealthtechHawthorne, US
Jonathan Levy(General Counsel and Secretary of the Issuer.)David Eigen(CEO)in
BoardJorey Chernett(Director)Carl Hirsh(Director)Hal Andrews(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.